Chongqing Lummy Pharmaceutical (300006) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.008x

Based on the latest financial reports, Chongqing Lummy Pharmaceutical (300006) has a cash flow conversion efficiency ratio of -0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-14.90 Million ≈ $-2.18 Million USD) by net assets (CN¥1.85 Billion ≈ $271.01 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Chongqing Lummy Pharmaceutical defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Chongqing Lummy Pharmaceutical - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Chongqing Lummy Pharmaceutical's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Chongqing Lummy Pharmaceutical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Chongqing Lummy Pharmaceutical ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Guangdong Senssun Weighing Apparatus Group Ltd
SHE:002870
0.049x
Guanghui Logistics Co Ltd
SHG:600603
0.005x
Compass Diversified Holdings
NYSE:CODI
0.045x
Nuh Cimento Sanayi AS
IS:NUHCM
0.028x
Costar Group Co Ltd
SHE:002189
0.005x
Shenzhen TXD Technology Co Ltd
SHE:002845
-0.017x
Inly Media Co Ltd
SHG:603598
-1.087x
Lloyds Banking Group PLC
LSE:LLOY
0.141x

Annual Cash Flow Conversion Efficiency for Chongqing Lummy Pharmaceutical (2006–2024)

The table below shows the annual cash flow conversion efficiency of Chongqing Lummy Pharmaceutical from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see Chongqing Lummy Pharmaceutical stock valuation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥1.88 Billion
≈ $275.59 Million
CN¥185.03 Million
≈ $27.08 Million
0.098x +155.72%
2023-12-31 CN¥2.12 Billion
≈ $310.54 Million
CN¥81.53 Million
≈ $11.93 Million
0.038x +46.92%
2022-12-31 CN¥2.18 Billion
≈ $319.73 Million
CN¥57.13 Million
≈ $8.36 Million
0.026x -46.58%
2021-12-31 CN¥2.21 Billion
≈ $323.70 Million
CN¥108.28 Million
≈ $15.84 Million
0.049x -73.15%
2020-12-31 CN¥1.23 Billion
≈ $180.22 Million
CN¥224.54 Million
≈ $32.86 Million
0.182x +30.35%
2019-12-31 CN¥1.65 Billion
≈ $241.99 Million
CN¥231.30 Million
≈ $33.85 Million
0.140x +6.75%
2018-12-31 CN¥1.72 Billion
≈ $252.28 Million
CN¥225.89 Million
≈ $33.05 Million
0.131x +267.72%
2017-12-31 CN¥1.72 Billion
≈ $252.11 Million
CN¥61.39 Million
≈ $8.98 Million
0.036x -52.53%
2016-12-31 CN¥1.67 Billion
≈ $245.00 Million
CN¥125.66 Million
≈ $18.39 Million
0.075x +599.18%
2015-12-31 CN¥1.69 Billion
≈ $247.28 Million
CN¥-25.41 Million
≈ $-3.72 Million
-0.015x +69.04%
2014-12-31 CN¥1.02 Billion
≈ $148.81 Million
CN¥-49.38 Million
≈ $-7.23 Million
-0.049x -173.18%
2013-12-31 CN¥1.13 Billion
≈ $164.73 Million
CN¥74.70 Million
≈ $10.93 Million
0.066x +159.29%
2012-12-31 CN¥710.51 Million
≈ $103.97 Million
CN¥18.18 Million
≈ $2.66 Million
0.026x +42.56%
2011-12-31 CN¥660.17 Million
≈ $96.60 Million
CN¥11.85 Million
≈ $1.73 Million
0.018x -73.23%
2010-12-31 CN¥561.59 Million
≈ $82.18 Million
CN¥37.66 Million
≈ $5.51 Million
0.067x -5.73%
2009-12-31 CN¥525.08 Million
≈ $76.84 Million
CN¥37.35 Million
≈ $5.47 Million
0.071x -43.18%
2008-12-31 CN¥137.79 Million
≈ $20.16 Million
CN¥17.25 Million
≈ $2.52 Million
0.125x -37.70%
2007-12-31 CN¥107.91 Million
≈ $15.79 Million
CN¥21.68 Million
≈ $3.17 Million
0.201x +66.59%
2006-12-31 CN¥64.39 Million
≈ $9.42 Million
CN¥7.77 Million
≈ $1.14 Million
0.121x --

About Chongqing Lummy Pharmaceutical

SHE:300006 China Drug Manufacturers - General
Market Cap
$760.20 Million
CN¥5.20 Billion CNY
Market Cap Rank
#10296 Global
#2797 in China
Share Price
CN¥4.92
Change (1 day)
-1.01%
52-Week Range
CN¥3.54 - CN¥6.58
All Time High
CN¥11.34
About

Chongqing Lummy Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. It provides anti-tumor, anti-inflammatory, antibacterial, digestive, anti-virus, blood system, cardiovascular system, acid-base balance nutritional medicine, endocrine system drugs, tumor adjuvant medication, antifungal, and opioid receptor antagonists. Chon… Read more